InvestorsHub Logo
Followers 471
Posts 25145
Boards Moderated 0
Alias Born 06/21/2016

Re: None

Monday, 01/15/2018 9:18:59 PM

Monday, January 15, 2018 9:18:59 PM

Post# of 18220
In September of 2017 IMUN/AHAR filed our application for the approval of Lodonal with NACA. NACA approval would provide the opportunity for purchases of Lodonal for HIV patients through the agency.The NACA regulatory paperwork is now under review and the Company hopes to have approval by Q1 of 2018.
---------------------------------------
As we are approaching Q1 of 2018.
glta..
-Chaka